Jane J. Zara

Array ( [id] => 5958478 [patent_doc_number] => 20110182865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Method for Prophylaxis and Treatment of Equine Herpesvirus Type 1 Infections' [patent_app_type] => utility [patent_app_number] => 12/866539 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10043 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182865.pdf [firstpage_image] =>[orig_patent_app_number] => 12866539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5423187 [patent_doc_number] => 20090149643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics' [patent_app_type] => utility [patent_app_number] => 12/322078 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 50862 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149643.pdf [firstpage_image] =>[orig_patent_app_number] => 12322078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575052 [patent_doc_number] => 20090142413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Targeted short-lived drug delivery' [patent_app_type] => utility [patent_app_number] => 12/321664 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12562 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142413.pdf [firstpage_image] =>[orig_patent_app_number] => 12321664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355066 [patent_doc_number] => 20090186410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'RNA SILENCING COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/348794 [patent_app_country] => US [patent_app_date] => 2009-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28348 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186410.pdf [firstpage_image] =>[orig_patent_app_number] => 12348794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490060 [patent_doc_number] => 20090291131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'SILENCING OF POLO-LIKE KINASE EXPRESSION USING INTERFERING RNA' [patent_app_type] => utility [patent_app_number] => 12/343342 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 66956 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291131.pdf [firstpage_image] =>[orig_patent_app_number] => 12343342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136107 [patent_doc_number] => 20110009281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'METHODS FOR CREATING AND IDENTIFYING FUNCTIONAL RNA INTERFERENCE ELEMENTS' [patent_app_type] => utility [patent_app_number] => 12/735222 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 37149 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009281.pdf [firstpage_image] =>[orig_patent_app_number] => 12735222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388914 [patent_doc_number] => 20100317715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/745886 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31528 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317715.pdf [firstpage_image] =>[orig_patent_app_number] => 12745886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6198315 [patent_doc_number] => 20110030073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'THERAPEUTIC TARGETS AND MEDICAMENTS INVOLVING P230/GOLGIN-245' [patent_app_type] => utility [patent_app_number] => 12/745536 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12195 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20110030073.pdf [firstpage_image] =>[orig_patent_app_number] => 12745536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586252 [patent_doc_number] => 20090105454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Prophylactic/therapeutic agent for cancer' [patent_app_type] => utility [patent_app_number] => 12/313983 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28627 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105454.pdf [firstpage_image] =>[orig_patent_app_number] => 12313983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6294588 [patent_doc_number] => 20100240058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'MicroRNA Antisense PNAs, Compositions Comprising the Same, and Methods for Using and Evaluating the Same' [patent_app_type] => utility [patent_app_number] => 12/741413 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6966 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240058.pdf [firstpage_image] =>[orig_patent_app_number] => 12741413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434985 [patent_doc_number] => 20090169571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'SELECTED MA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 12/271779 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9674 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169571.pdf [firstpage_image] =>[orig_patent_app_number] => 12271779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187969 [patent_doc_number] => 20110171287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Use of Oligonucleotides with Modified Bases as Antiviral Agents' [patent_app_type] => utility [patent_app_number] => 12/741531 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 28179 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171287.pdf [firstpage_image] =>[orig_patent_app_number] => 12741531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196650 [patent_doc_number] => 20110028408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => ' DIAGNOSTIC MOLECULE AND THERAPEUTIC TARGET' [patent_app_type] => utility [patent_app_number] => 12/740805 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22196 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028408.pdf [firstpage_image] =>[orig_patent_app_number] => 12740805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277885 [patent_doc_number] => 20090130017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Targeted short-lived drug delivery' [patent_app_type] => utility [patent_app_number] => 12/290457 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12562 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130017.pdf [firstpage_image] =>[orig_patent_app_number] => 12290457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434899 [patent_doc_number] => 20090169485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Gene therapy and pharmaceutical composition for prevention and treatment of lung cancer' [patent_app_type] => utility [patent_app_number] => 12/285867 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4690 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169485.pdf [firstpage_image] =>[orig_patent_app_number] => 12285867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441349 [patent_doc_number] => 20090092988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Modulating Gene Expression with agRNA and Gapmers Targeting Antisense Transcripts' [patent_app_type] => utility [patent_app_number] => 12/246421 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8289 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092988.pdf [firstpage_image] =>[orig_patent_app_number] => 12246421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458778 [patent_doc_number] => 20090258930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'DOUBLE STRANDED RNA STRUCTURES AND CONSTRUCTS, AND METHODS FOR GENERATING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/246258 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 50446 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258930.pdf [firstpage_image] =>[orig_patent_app_number] => 12246258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279228 [patent_doc_number] => 20090131360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Tripartite RNAi constructs' [patent_app_type] => utility [patent_app_number] => 12/286896 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16912 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131360.pdf [firstpage_image] =>[orig_patent_app_number] => 12286896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7683675 [patent_doc_number] => 20100240736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Novel Compounds for the Treatment or Alleviation of Edema, and Methods for their Use' [patent_app_type] => utility [patent_app_number] => 12/681590 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10453 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240736.pdf [firstpage_image] =>[orig_patent_app_number] => 12681590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585977 [patent_doc_number] => 20090105179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'DRUG CARRIERS' [patent_app_type] => utility [patent_app_number] => 12/210098 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18753 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105179.pdf [firstpage_image] =>[orig_patent_app_number] => 12210098 [rel_patent_id] =>[rel_patent_doc_number] =>)